This inventor holds 8 USPTO granted patents and 5 published patent applications. Top assignees: Nanocopoeia, LLC, Flex Pharma, Inc.. Active years: 2022-2026.
Company Filing History:
Years Active: 2022-2026
Title: Joseph McTarsney: Innovator in Pharmaceutical Compositions
Introduction
Joseph McTarsney is a notable inventor based in Shakopee, Minnesota. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for treating proliferative disorders such as cancer. With a total of six patents to his name, McTarsney's work is paving the way for advancements in cancer treatment.
Latest Patents
Among his latest patents are the formulations of amorphous nilotinib microparticles and their uses. These amorphous solid dispersions and pharmaceutical compositions of the protein kinase inhibitor nilotinib are designed to enhance therapeutic efficacy. Notably, these compositions can be administered without regard to food consumption, providing flexibility for patients. Furthermore, they can be given at significantly lower doses compared to commercially available immediate-release nilotinib formulations, while still delivering comparable therapeutic effects.
Career Highlights
Joseph McTarsney is currently associated with Nanocopoeia, LLC, where he continues to innovate in the pharmaceutical sector. His work focuses on improving drug delivery systems and enhancing the effectiveness of existing treatments. His dedication to research and development has positioned him as a key player in the industry.
Collaborations
McTarsney collaborates with talented individuals such as Christian F Wertz and Tzehaw Chen. These partnerships foster a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions in pharmaceuticals.
Conclusion
Joseph McTarsney's contributions to the field of pharmaceuticals, particularly through his innovative patents, are making a significant impact on cancer treatment. His work exemplifies the importance of research and collaboration in advancing medical science.